Technology Acceleration & Commercialization (TAC) Awards Announcement

Dear Colleagues:

As part of New York University's commitment to research excellence, technology transfer, and entrepreneurship, we are pleased to announce the fifth annual call for proposals for the Technology Acceleration & Commercialization (TAC) Awards.

The purpose of the Awards is to encourage and promote the development of research projects and technologies that have the near-term potential for commercialization through start-up creation or licensing. The Awards can support projects from NYU's Washington Square, Dental School, Nursing School, Tandon Engineering, Abu Dhabi, and Shanghai campuses.

Applicants may request up to a maximum budget of $50,000 in direct costs. Funding is ordinarily for one year and is non-renewable. Successful applications should relate to technology for which intellectual property has been obtained or will be sought by NYU, and should seek to advance the commercial development of the technology through prototype development, proof-of-concept studies, etc. To be considered for this annual round, please submit a one-page preliminary proposal to the Office of Industrial Liaison (OIL) by November 30, 2019, describing the technology to be developed and its commercial potential. Following review for scientific merit and commercial potential, selected applicants will be invited to submit full 3-5 page proposals. Funding is expected to start April 1, 2020.

Applications should be emailed to A confirmation will be emailed to you within 2 business days of receipt.

For more information, contact the NYU Office of Industrial Liaison at 212-263-8178 or visit our website

Stacie Grossman Bloom
Vice Provost for Research

Abram M. Goldfinger
Executive Director, Industrial Liaison/Technology Transfer

About Technology Transfer at NYU

The mission of the Technology Transfer program at NYU is to promote the commercial development of NYU technologies, into products to benefit society, while providing a return to the University to support its research and education missions. NYU has one of the most successful track records of commercializing technology of any university, with over 45 products based on NYU technology having been brought to market to benefit society and over 150 start-up companies having been created (including 7 funded by prior TAC awards). Products developed include drugs for the treatment of cancer, arthritis, and psoriasis, numerous medical and dental devices and diagnostics, and electronics and software technologies. Numerous additional products are currently under development by licensees and start-up companies, including semiconductors, electronic systems, software, agricultural, medical, and dental products.

Over the past 10 years, NYU has generated 50% more start-up companies based on licensed technology per dollar of research expenditures, than the national average, and has ranked first in overall license income generated from successful technology commercialization. Revenues generated from technology commercialization are shared with the inventors under the NYU Patent Policy, which is one of the most generous in the country, and the remainder is devoted to supporting the research activities of the University. In FY19, the number of new start-ups created more than doubled, with 18 being created; a total of 74 new license agreements with industry were signed, a 45% increase from FY18; and prior NYU start-ups completed 2 IPOs and a major acquisition, and many more completed key product development and financing milestones.

The Office of Industrial Liaison, part of the NYU Provost's Office, is responsible for managing activities relating to the protection and commercial promotion of inventions made at New York University, as well as research collaborations with industry.

Faculty, staff, and students whose research may lead to new discoveries or products are encouraged to contact the Office of Industrial Liaison as early as possible, to discuss their work. Under patent laws, patent applications must be filed prior to any publication or presentation of the invention to avoid loss of rights. By contacting the Office early, patent protection can be sought if appropriate, without delays in publishing and presenting new results.